Moderna to Supply 500 Million Covid-19 Vaccine Doses to Covax

The transcript discusses the challenges and strategies in vaccine production and distribution, focusing on Moderna's efforts to increase supply and address global needs. It highlights the importance of pricing strategies, the impact of new variants, and the need for booster shots. The conversation also covers future production goals, long-term planning for potential endemic behavior of the virus, and the role of Kovacs in achieving herd immunity. The importance of vaccinating children and the unknown long-term effects of the virus are also discussed.

How does the speaker view the role of investment in vaccine production?

What strategies are being considered to address the potential endemic nature of the virus?

What is the significance of vaccinating children in the context of herd immunity?